Provided by Tiger Trade Technology Pte. Ltd.

Alnylam Pharmaceuticals

236.22
+6.923.02%
Post-market: 236.480.2586+0.11%19:58 EDT
Volume:1.91M
Turnover:449.27M
Market Cap:31.52B
PE:42.04
High:238.97
Open:228.88
Low:228.34
Close:229.30
52wk High:495.55
52wk Low:197.81
Shares:133.43M
Float Shares:133.16M
Volume Ratio:1.16
T/O Rate:1.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.62
EPS(LYR):2.33
ROE:96.55%
ROA:12.34%
PB:23.28
PE(LYR):101.38

Loading ...

BUZZ - Nasdaq top and bottom performing stocks at about 02:45 p.m. EDT on 2026-04-24

Reuters
·
Apr 25

Earning Preview: Alnylam Pharmaceuticals revenue is expected to increase by 90.11%, and institutional views are broadly bullish

Earnings Agent
·
Apr 23

BUZZ - Nasdaq top and bottom performing stocks at about 02:45 p.m. EDT on 2026-04-17

Reuters
·
Apr 18

BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2026-04-16

Reuters
·
Apr 16

Alnylam schedules webcast conference call to discuss first-quarter results

Reuters
·
Apr 16

Alnylam Pharmaceuticals Inc : Leerink Partners Raises Target Price to $362 From $357

THOMSON REUTERS
·
Apr 16

U.S. RESEARCH ROUNDUP-CME Group, M&T Bank, PNC Financial Services

Reuters
·
Apr 16

Analysts Have Conflicting Sentiments on These Healthcare Companies: Alnylam Pharma (ALNY) and Apellis Pharmaceuticals (APLS)

TIPRANKS
·
Apr 15

Alnylam Pharmaceuticals Is Maintained at Buy by Truist Securities

Dow Jones
·
Apr 14

Alnylam Pharmaceuticals Inc : Truist Securities Cuts Target Price to $505 From $515

THOMSON REUTERS
·
Apr 13

U.S. RESEARCH ROUNDUP-Chevron, Ford, Occidental Petroleum

Reuters
·
Apr 13

Alnylam CHRO Melissa McLaughlin disposes of common shares worth $1,003,169.76

Reuters
·
Apr 08

BUZZ - Nasdaq top and bottom performing stocks at about 02:45 p.m. EDT on 2026-04-07

Reuters
·
Apr 08

How New Vutrisiran Outcomes and Zilebesiran Safety Data Will Impact Alnylam Pharmaceuticals (ALNY) Investors

Simply Wall St.
·
Apr 07

An S&P 500 change may be imminent. These stocks are leading contenders to join the index.

Dow Jones
·
Apr 07

Genmab names Margarida Duarte general manager for Europe and emerging markets

Reuters
·
Apr 01

Piper Sandler Sticks to Their Buy Rating for Alnylam Pharma (ALNY)

TIPRANKS
·
Mar 31

Alnylam’s zilebesiran Phase 2 safety data backs ongoing Phase 3 ZENITH hypertension trial

Reuters
·
Mar 31

3 Stocks That May Be Trading Up To 43.2% Below Intrinsic Value Estimates

Simply Wall St.
·
Mar 30

Alnylam Pharmaceuticals Price Target Maintained With a $510.00/Share by HC Wainwright & Co.

Dow Jones
·
Mar 26